Post-translational modifications of Runx1 regulate its activity in the cell

Por Wang, Lan, Huang, Gang, Zhao, Xinyang, Hatlen, Megan A., Vu, Ly, Liu, Fan, Nimer, Stephen D.
Publicado em 2009

Highly selective hydrodeoxygenation of wood pallet sawdust pyrolysis oil to methyl phenol derivatives using cobalt and iron on activated carbon supported catalysts

Por Quoc Khanh Tran, Hoang Vu Ly, Thuan Anh Vo, Hyun Tae Hwang, Jinsoo Kim, Seung-Soo Kim
Publicado em 2022-05-01

The Polycomb Group Protein L3MBTL1 Represses a SMAD5-Mediated Hematopoietic Transcriptional Program in Human Pluripotent Stem Cells

Por Perna, Fabiana, Vu, Ly P., Themeli, Maria, Kriks, Sonja, Hoya-Arias, Ruben, Khanin, Raya, Hricik, Todd, Mansilla-Soto, Jorge, Papapetrou, Eirini P., Levine, Ross L., Studer, Lorenz, Sadelain, Michel, Nimer, Stephen D.
Publicado no Stem Cell Reports (2015)

PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex

Por Vu, Ly P., Perna, Fabiana, Wang, Lan, Voza, Francesca, Figueroa, Maria E., Tempst, Paul, Erdjument-Bromage, Hediye, Gao, Rui, Chen, Sisi, Paietta, Elisabeth, Deblasio, Tony, Melnick, Ari, Liu, Yan, Zhao, Xinyang, Nimer, Stephen D.
Publicado em 2013

Musashi2 sustains the mixed-lineage leukemia–driven stem cell regulatory program

Por Park, Sun-Mi, Gönen, Mithat, Vu, Ly, Minuesa, Gerard, Tivnan, Patrick, Barlowe, Trevor S., Taggart, James, Lu, Yuheng, Deering, Raquel P., Hacohen, Nir, Figueroa, Maria E., Paietta, Elisabeth, Fernandez, Hugo F., Tallman, Martin S., Melnick, Ari, Levine, Ross, Leslie, Christina, Lengner, Christopher J., Kharas, Michael G.
Publicado no J Clin Invest (2015)

The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation

Por Wang, Lan, Gural, Alexander, Sun, Xiao-Jian, Zhao, Xinyang, Perna, Fabiana, Huang, Gang, Hatlen, Megan A., Vu, Ly, Liu, Fan, Xu, Haiming, Asai, Takashi, Xu, Hao, Deblasio, Tony, Menendez, Silvia, Voza, Francesca, Jiang, Yanwen, Cole, Philip A., Zhang, Jinsong, Melnick, Ari, Roeder, Robert G., Nimer, Stephen D.
Publicado em 2011

MSI2 is required for maintaining activated myelodysplastic syndrome stem cells

Por Taggart, James, Ho, Tzu-Chieh, Amin, Elianna, Xu, Haiming, Barlowe, Trevor S., Perez, Alexendar R., Durham, Benjamin H., Tivnan, Patrick, Okabe, Rachel, Chow, Arthur, Vu, Ly, Park, Sun Mi, Prieto, Camila, Famulare, Christopher, Patel, Minal, Lengner, Christopher J., Verma, Amit, Roboz, Gail, Guzman, Monica, Klimek, Virginia M., Abdel-Wahab, Omar, Leslie, Christina, Nimer, Stephen D., Kharas, Michael G.
Publicado no Nat Commun (2016)

Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90

Por Moulick, Kamalika, Ahn, James H, Zong, Hongliang, Rodina, Anna, Cerchietti, Leandro, Gomes DaGama, Erica M, Caldas-Lopes, Eloisi, Beebe, Kristin, Perna, Fabiana, Hatzi, Katerina, Vu, Ly P, Zhao, Xinyang, Zatorska, Danuta, Taldone, Tony, Smith-Jones, Peter, Alpaugh, Mary, Gross, Steven S, Pillarsetty, Nagavarakishore, Ku, Thomas, Lewis, Jason S, Larson, Steven M, Levine, Ross, Erdjument-Bromage, Hediye, Guzman, Monica L, Nimer, Stephen D, Melnick, Ari, Neckers, Len, Chiosis, Gabriela
Publicado em 2011

Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias

Por Wang, Kai, Sanchez-Martin, Marta, Wang, Xujun, Knapp, Kristina M., Koche, Richard, Vu, Ly, Nahas, Michelle K., He, Jie, Hadler, Michael, Stein, Eytan M, Tallman, Martin S., Donahue, Amy L, Frampton, Garrett M, Lipson, Doron, Roels, Steven, Stephens, Philip J., Sanford, Eric M, Brennan, Tim, Otto, Geoff A., Yelensky, Roman, Miller, Vincent A., Kharas, Michael G., Levine, Ross L., Ferrando, Adolfo, Armstrong, Scott A., Krivtsov, Andrei V.
Publicado no Leukemia (2016)